Impedimetric sensor for alzheimer's biomarker detection

MYPI2017001146A0Undetermined Publication Date: 2019-02-03ZAINIHARYATI BINTI MOHD ZAIN +3
0 Cites 0 Cited by

Patent Information

Application Number
MYPI2017001146
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Filing Date
2017-08-03
Publication Date
2019-02-03
Patent Text Reader

Abstract

THE APPLICATION OF SIMPLE, COST-EFFECTIVE, RAPID, AND ACCURATE DIAGNOSTIC TECHNOLOGIES FOR DETECTION AND IDENTIFICATION OF ALZHEIMER’S DISEASE BIOMARKERS HAS BEEN A CENTRAL POINT IN THE CLINICAL AREA. IMMUNOSENSORS HAVE BEEN RECOGNIZED AS EFFICIENT ALTERNATIVES FOR THE DIAGNOSTICS OF VARIOUS DISEASES DUE TO THEIR SPECIFICITY AND POTENTIAL FOR APPLICATION ON REAL SAMPLES. A MINIATURIZED BIOSENSING PLATFORM BASED ON MONOCLONAL AMYLOID-BETA ANTIBODIES (MA()AB) THAT WERE COVALENTLY IMMOBILIZED ON PLATINUM / IRIDIUM (PT / LR) DISC MICROELECTRODE SURFACE COUPLED WITH AN IMPEDIMETRIC SIGNAL TRANSDUCER HAS BEEN DEVELOPED FOR A LABEL-FREE AND SENSITIVE DETECTION OF AMYLOID-BETA PEPTIDE FRAGMENT 1-40 (A40) IN BRAIN LYSATES. THE PT / LR DISC MICROELECTRODE SURFACE WAS ELECTROPOLYMERIZED WITH POLY (ORTHO-PHENYLENEDIAMINE), A FREE AMINE-CONTAINING AROMATIC CONDUCTING POLYMER; FOLLOWED BY SUBSEQUENT COVALENT COUPLING OF MA()AB THAT WAS CROSSLINKED USING GLUTARALDEHYDE ON THE MICROELECTRODE SURFACE. THIS BLOMODIFICATION STRATEGY EFFICIENTLY IMPROVED THE IMPEDIMETRIC DETECTION PERFORMANCE OF A40 IN THE REAL APPLICABILITY, THE DEVELOPED IMMUNOSENSOR WAS EVALUATED IN BRAIN TISSUE LYSATE FROM SPRAGUE DAWLEY RATS CONTAINING A4O IN VARIOUS GROUP SAMPLES. THE PROPOSED IMPEDIMETRIC MICRO-IMMUNOSENSING PLATFORM IS HIGHLY VERSATILE AND ADAPTABLE FOR THE QUANTITATIVE DETECTION OF OTHER DISEASE-RELATED BIOMARKERS.
Need to check novelty before this filing date? Find Prior Art